Other
Common Stock, Shares, Outstanding
Alnylam Pharmaceuticals Common Stock, Shares, Outstanding increased by 0.8% to $133.44M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $130.31M to $133.44M. Over 5 years (FY 2020 to FY 2025), Common Stock, Shares, Outstanding shows an upward trend with a 2.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase suggests share issuance (dilution), while a decrease indicates share buybacks (accretion).
Detailed definition
This is the total number of shares currently held by all shareholders, including institutional investors and company ins...
Peer comparison
Standard metric for all public companies; essential for valuation and ownership analysis.
Metric ID:
other_common_stock_shares_outstandingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $118.60M | $119.48M | $120.18M | $120.73M | $120.99M | $122.99M | $123.93M | $124.24M | $124.90M | $125.45M | $125.79M | $126.46M | $128.02M | $128.84M | $129.29M | $130.31M | $130.98M | $131.79M | $132.38M | $133.44M |
| QoQ Change | — | +0.7% | +0.6% | +0.5% | +0.2% | +1.7% | +0.8% | +0.3% | +0.5% | +0.4% | +0.3% | +0.5% | +1.2% | +0.6% | +0.4% | +0.8% | +0.5% | +0.6% | +0.4% | +0.8% |
| YoY Change | — | — | — | — | +2.0% | +2.9% | +3.1% | +2.9% | +3.2% | +2.0% | +1.5% | +1.8% | +2.5% | +2.7% | +2.8% | +3.0% | +2.3% | +2.3% | +2.4% | +2.4% |
Range$118.60M – $133.44M
CAGR+2.5%
Avg YoY Growth+2.5%
Median YoY Growth+2.5%
Current Streak19+ quarters growth
Common Stock, Shares, Outstanding at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's common stock, shares, outstanding?
- Alnylam Pharmaceuticals (ALNY) reported common stock, shares, outstanding of $133.44M in Q1 2026.
- How has Alnylam Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
- Alnylam Pharmaceuticals's common stock, shares, outstanding increased by 2.4% year-over-year, from $130.31M to $133.44M.
- What is the long-term trend for Alnylam Pharmaceuticals's common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's common stock, shares, outstanding has grown at a 2.6% compound annual growth rate (CAGR), from $116.43M to $132.38M.
- What does common stock, shares, outstanding mean?
- The total number of shares currently held by investors.